1. Home
  2. EDBL vs ARTL Comparison

EDBL vs ARTL Comparison

Compare EDBL & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

N/A

Current Price

$0.65

Market Cap

1.4M

ML Signal

N/A

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$2.13

Market Cap

1.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDBL
ARTL
Founded
2020
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
EDBL
ARTL
Price
$0.65
$2.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 48.3K
26.6K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $12,810,000.00
N/A
Revenue This Year
$24.00
N/A
Revenue Next Year
$282.47
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.08
$0.52
52 Week High
$14.90
$179.19

Technical Indicators

Market Signals
Indicator
EDBL
ARTL
Relative Strength Index (RSI) 30.70 35.55
Support Level $0.18 $1.98
Resistance Level $1.20 $6.81
Average True Range (ATR) 0.07 0.22
MACD 0.02 0.08
Stochastic Oscillator 23.10 29.00

Price Performance

Historical Comparison
EDBL
ARTL

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. Company provides two principal product segments: (i) fresh produce, including cut herbs, hydroponic basil, potted herbs, and wheatgrass; and (ii) shelf-stable and refrigerated consumer packaged goods, including sports nutrition and nutraceuticals.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: